Elleacnelle is a combined hormonal tablet formulation delivering Cyproterone Acetate 2000mcg and Ethinylestradiol 35mcg in a fixed ratio dual compound presentation. Combining an antiandrogen with a synthetic estrogen in a single tablet format that has been clinically referenced in dermatological and endocrine research contexts examining combined androgen suppression and estrogen activity. The 4 pack format supplies a structured multi cycle research quantity designed for extended hormonal modulation protocols requiring consistent compound availability across multiple administration periods.

Cyproterone Acetate is a steroidal antiandrogen and progestogen with a well documented pharmaceutical history spanning several decades of clinical application. Its primary mechanism operates through competitive androgen receptor antagonism, blocking dihydrotestosterone and testosterone from binding androgen receptors in target tissue, reducing androgenic stimulation in skin, hair follicles, and other androgen sensitive tissues. Cyproterone Acetate additionally carries progestogenic activity through progesterone receptor binding, producing gonadotropin suppression through negative feedback on the HPG axis. Reducing endogenous LH and FSH secretion and consequently lowering endogenous androgen production alongside its direct receptor blocking activity. This dual mechanism of peripheral androgen receptor blockade and central gonadotropin suppression makes Cyproterone Acetate a frequently studied reference compound in androgen dependent pathway research examining both receptor level and production level androgen regulation.

Ethinylestradiol is a synthetic estrogen with high oral bioavailability; the most widely used synthetic estrogen in pharmaceutical research due to its resistance to first pass hepatic metabolism that limits native estradiol’s oral activity. In this combination formulation, Ethinylestradiol’s estrogenic activity complements Cyproterone Acetate’s antiandrogen and gonadotropin suppressing effects. The combined estrogen and antiandrogen profile producing a well characterized hormonal research environment that has been studied in androgen excess, sebaceous gland activity, and combined sex hormone modulation research contexts. The fixed ratio combination of both compounds in a single tablet supports consistent dual compound administration research without separate dosing of individual components.

Elleacnelle is stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all products we carry, and Elleacnelle meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Store in a cool, dry place away from direct light and heat. Intended for research purposes only.

Commonly researched alongside androgen receptor modulators and hormonal regulation compounds in comparative sex hormone pathway studies. Browse CSD’s full PCT and hormone research range for complete sourcing.